Used in neuroscience and Alzheimer's disease research to quantify total amyloid-beta (Aβ) peptide levels in biological samples such as cell lysates, brain tissue homogenates, cerebrospinal fluid (CSF), and plasma. Enables researchers to monitor Aβ accumulation, a key pathological feature of Alzheimer's disease, in preclinical studies and drug development. Commonly applied in studies assessing the efficacy of therapeutic agents targeting amyloid plaque formation. Supports high-throughput screening and biomarker validation in neurodegenerative disease models.